JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Pasireotide, formerly known as SOM230, is a potent and stable cyclohexapeptide somatostatin mimic that exhibits uniquehigh-affinity binding to human somatostatin receptors (subtypessst1/2/3/4/5, pKi=8.2/9.0/9.1/< 7.0/9.9 respectively). It is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analogue with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogues.
References:
1. LewisI, et al. A novel somatostatin mimic with broad somatotropin releaseinhibitory factor receptor binding and superior therapeutic potential. JMed Chem. 2003 Jun 5; 46(12):2334-44.
2. HoflandLJ, et al. The novel somatostatin analog SOM230 is a potent inhibitorof hormone release by growth hormone- and prolactin-secreting pituitaryadenomas in vitro. J Clin Endocrinol Metab. 2004 Apr; 89(4):1577-85.
3. MurrayRD, et al. The novel somatostatin ligand (SOM230) regulates human andrat anterior pituitary hormone secretion. J Clin Endocrinol Metab. 2004Jun; 89(6):3027-32.
4. QuinnTJ, et al. Pasireotide (SOM230) is effective for the treatment ofpancreatic neuroendocrine tumors (PNETs) in a multiple endocrineneoplasia type 1 (MEN1) conditional knockout mouse model. Surgery. 2012Dec; 152(6):1068-77.
5. ImhofAK, et al. Differential antiinflammatory and antinociceptive effects ofthe somatostatin analogs octreotide and pasireotide in a mouse model ofimmune-mediated arthritis. Arthritis Rheum. 2011 Aug; 63(8):2352-62.
Related CAS #: 396091-73-9 (free base) 396091-76-2 (acetate) 396091-79-5 (pamoate) 820232-50-6 (diaspartate)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!